Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
PFIZER On Other Exchanges
Symbol
Exchange
PFIZER is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

pfizer limited (PFIZER) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PFIZER LIMITED (PFIZER)

Related News

No related news articles were found.

pfizer limited (PFIZER) Related Businessweek News

No Related Businessweek News Found

pfizer limited (PFIZER) Details

Pfizer Limited engages in the manufacture, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers prescription medicines and consumer healthcare products in the areas of anti-allergic, anti-diabetic, antihistamine, anti-infectives, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, GI, multivitamins, neurology, pain/fever/inflammation, pain/inflammation, pediatrics, pediatrics, psychiatry, respiratory, urology, and vitamin/minerals. It sells its products through independent distributors primarily in India. The company was incorporated in 1950 and is headquartered in Mumbai, India. Pfizer Limited is a subsidiary of Pfizer East India BV.

Founded in 1950

pfizer limited (PFIZER) Top Compensated Officers

Managing Director, Director, Member of Nomina...
Total Annual Compensation: 30.3M
Business Unit Head, Whole-Time Director and M...
Total Annual Compensation: 12.7M
Executive Director of Technical Operations, W...
Total Annual Compensation: 10.6M
Compensation as of Fiscal Year 2014.

pfizer limited (PFIZER) Key Developments

Pfizer Limited Announces Executive Changes

Pfizer Limited announced that Mr. S. Sridhar, the Chief Financial Officer of the company, will be moving to a new role as Business Unit Head effective close of business on May 12, 2015, consequently, Mr. S. Sridhar will cease to be the Chief Financial Officer of the company effective the said date. Mr. Ravi Prakash Bhagavathula has been appointed as the Chief Financial Officer of the company effective May 13, 2015.

Pfizer Limited Provides Update on Conciliation with Workers Union

Pfizer Limited announced that a matter of conciliation between the Workers Union and Management of its manufacturing facility at Goa is being heard at the State Labour Commissioner's office. This follows a charter of demands submitted by the Union. The Management hopes to resolve the matter expeditiously. There is a temporary impact on production for which the Company is putting into place contingency measures.

Pfizer Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Pfizer Limited announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported net sales of INR 4,563.1 million against INR 2,516.9 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 911.4 million against INR 708.8 million a year ago. Profit from ordinary activities before tax was INR 1,097.4 million against INR 870.0 million a year ago. Profit for the year was INR 426.8 million or INR 9.33 basic and diluted per share against INR 560.3 million or INR 18.78 basic and diluted per share a year ago. For the year, the company reported net sales of INR 18,277.4 million against INR 10,042.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 2,518.9 million against INR 2,305.6 million a year ago. Profit from ordinary activities before tax was INR 2,380.2 million against INR 3,395.8 million a year ago. Profit for the year was INR 698.2 million or INR 15.26 basic and diluted per share against INR 2,208.5 million or INR 74.01 basic and diluted per share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFIZ:IN 2,216.85 INR 0.00

PFIZER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 4,041 INR +72.70
ARIAD Pharmaceuticals Inc $9.18 USD +0.18
Array BioPharma Inc $7.65 USD +0.01
Merit Medical Systems Inc $20.56 USD +0.06
Sanofi India Ltd 3,487 INR +42.15
View Industry Companies
 

Industry Analysis

PFIZER

Industry Average

Valuation PFIZER Industry Range
Price/Earnings 100.0x
Price/Sales 5.3x
Price/Book 5.0x
Price/Cash Flow 49.1x
TEV/Sales 5.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER LIMITED, please visit www.pfizerindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.